Series C financing
Series C financing
Catalym Raises $150m for Cancer Breakthrough
BIOT
💰 German cancer specialist Catalym GmbH raises $150m to fund proof-of-concept studies 🔬💉🧪💼 Exciting progress in solid tumor treatment!
Cancer ADC Specialist Myricx Bio Secures £90m in Funding Expanding Pipeline and Board
BIOT
📢 Novo Holdings AS and Abingworth co-lead £90m financing in Myricx Bio Ltd, with plans to expand their ADC platform. 💰
Swiss Antibody Specialist Secures CHF 45m Funding for Groundbreaking Research
BIOT
💰 Swiss antibody specialist Memo Therapeutics AG secures CHF 45m in Series C financing, including CHF 20m from new investors. 🧪💉🌡️
